| 2024-06-04 | Sale | BridgeBio Pharma, Inc. BBIO | director | 1,500 0.0009% | $31.30 | $46,950 | +0.99% | |
| 2024-06-03 | Sale | BridgeBio Pharma, Inc. BBIO | director | 1,000 0.0005% | $28.84 | $28,843 | -5.59% | |
| 2024-03-01 | Sale | BridgeBio Pharma, Inc. BBIO | director | 2,500 0.0014% | $34.00 | $85,000 | -21.47% | |
| 2023-12-18 | Sale | BridgeBio Pharma, Inc. BBIO | director | 2,000 0.0012% | $40.00 | $80,000 | -23.81% | |
| 2023-12-01 | Sale | BridgeBio Pharma, Inc. BBIO | director | 2,500 0.0014% | $29.40 | $73,500 | -2.94% | |
| 2023-09-05 | Sale | BridgeBio Pharma, Inc. BBIO | director | 2,500 0.0016% | $30.00 | $75,000 | -2.67% | |
| 2021-05-17 | Talis Biomedical Corporation TLIS | director | 11,000 0.0426% | $10.11 | $111,210 | -51.03% | ||
| 2021-05-14 | Talis Biomedical Corporation TLIS | director | 9,000 0.0354% | $10.16 | $91,440 | -47.52% | ||
| 2021-02-17 | BridgeBio Pharma, Inc. BBIO | director | 16,000 0.0111% | $62.50 | $1M | -21.37% | ||
| 2021-02-17 | Talis Biomedical Corporation TLIS | director | 312,500 1.5752% | $16.00 | $5M | -65.14% |